NCT00416923View on ClinicalTrials.gov

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

November 30, 2005

Study Completion Date

April 30, 2007

Conditions
Brain and Central Nervous System TumorsLymphoma
Interventions
BIOLOGICAL

rituximab

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00416923 - Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma | Biotech Hunter | Biotech Hunter